Figures & data
Figure 1 Schematic structure of p53 showing the different domains. Mutations frequently occur within the DNA-binding domain. Commonly mutated codons/residues are shown in red.
Figure 2 Strategy for targeting conformationally altered mutant p53 by small molecule drugs to regain anti-tumor functions. Triangles depict altered shape of wild-type p53 protein which accumulates in cells.
